Monitoring BCR-ABL transcript levels by real-time quantitative polymerase chain reaction: a linear regression equation to convert from BCR-ABL/B2M ratio to estimated BCR-ABL/ABL ratio

被引：7
作者：
Iacobucci, Ilaria [1 ]
Galletti, Livia [1 ]
Amabile, Marilina [1 ]
Soverini, Simona [1 ]
Baccarani, Michele [1 ]
Martinelli, Giovanni [1 ]
机构：
[1] Univ Bologna, S Orsola Malpighi Hosp, Dept Hematol Oncol L&A Seragnoli, Bologna, Italy
来源：
HAEMATOLOGICA | 2007年 / 92卷 / 03期
关键词：
BCR-ABL ratio; RT-PCR;
D O I：
10.3324/haematol.10632
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
In order to overcome the problem of different control genes for BCR-ABL normalization, we used a linear regression equation to compare our results previously obtained using B2M as the control gene with those calculated using the ABL gene and validated the slope as a factor to convert from B2M to ABL results.
引用
收藏
页码：429 / 430
页数：2
相关论文
共 8 条
  • [1] Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) - a Europe against cancer program
    Beillard, E
    Pallisgaard, N
    van der Velden, VHJ
    Bi, W
    Dee, R
    van der Schoot, E
    Delabesse, E
    Macintyre, E
    Gottardi, E
    Saglio, G
    Watzinger, F
    Lion, T
    van Dongen, JJM
    Hokland, P
    Gabert, J
    [J]. LEUKEMIA, 2003, 17 (12) : 2474 - 2486
  • [2] Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia -: A Europe Against Cancer Program
    Gabert, J
    Beillard, E
    van der Velden, VHJ
    Bi, W
    Grimwade, D
    Pallisgaard, N
    Barbany, G
    Cazzaniga, G
    Cayuela, JM
    Cavé, H
    Pane, F
    Aerts, JLE
    De Micheli, D
    Thirion, X
    Pradel, V
    González, M
    Viehmann, S
    Malec, M
    Saglio, G
    van Dongen, JJM
    [J]. LEUKEMIA, 2003, 17 (12) : 2318 - 2357
  • [3] Monitoring CML patients responding to treatment with tyrosine kinase inhibitors:: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results
    Hughes, Timothy
    Deininger, Michael
    Hochhaus, Andreas
    Branford, Susan
    Radich, Jerald
    Kaecla, Jaspal
    Baccarani, Michele
    Cortes, Jorge
    Cross, Nicholas C. P.
    Druker, Brian J.
    Gabert, Jean
    Grimwade, David
    Hehlmann, Ruediger
    Kamel-Reid, Suzanne
    Lipton, Jeffrey H.
    Longtine, Janina
    Martinelli, Giovanni
    Saglio, Giuseppe
    Soverini, Simona
    Stock, Wendy
    Goldman, John M.
    [J]. BLOOD, 2006, 108 (01) : 28 - 37
  • [4] Comparison between patients with Philadelphia-positive chronic phase chronic myeloid leukemia who obtained a complete cytogenetic response within 1 year of imatinib therapy and those who achieved such a response after 12 months of treatment
    Iacobucci, I
    Rosti, G
    Amabile, M
    Poerio, A
    Soverini, S
    Cilloni, D
    Testoni, N
    Abruzzese, E
    Montefusco, E
    Ottaviani, E
    Iuliano, F
    Russo, D
    Gobbi, M
    Alimena, G
    Martino, B
    Terragna, C
    Pane, F
    Saglio, G
    Baccarani, M
    Martinelli, G
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (03) : 454 - 459
  • [5] Prediction of response to imatinib by prospective quantitation of BCR-ABL transcript in late chronic phase chronic myeloid leukemia patients
    Martinelli, G
    Iacobucci, I
    Rosti, G
    Pane, F
    Amabile, M
    Castagnetti, F
    Cilloni, D
    Soverini, S
    Testoni, N
    Specchia, G
    Merante, S
    Zaccaria, A
    Frassoni, F
    Saglio, G
    Baccarani, M
    [J]. ANNALS OF ONCOLOGY, 2006, 17 (03) : 495 - 502
  • [6] Monitoring minimal residual disease and controlling drug resistance in chronic myeloid leukaemia patients in treatment with imatinib as a guide to clinical management
    Martinelli, Giovanni
    Iacobucci, Ilaria
    Soverini, Simona
    Cilloni, Daniela
    Saglio, Giuseppe
    Pane, Fabrizio
    Baccarani, Michele
    [J]. HEMATOLOGICAL ONCOLOGY, 2006, 24 (04) : 196 - 204
  • [7] Molecular response to imatinib in late chronic-phase chronic myeloid leukemia
    Rosti, G
    Martinelli, G
    Bassi, S
    Amabile, M
    Trabacchi, E
    Giannini, B
    Cilloni, D
    Izzo, B
    De Vivo, A
    Testoni, N
    Cambrin, GR
    Bonifazi, F
    Soverini, S
    Luatti, S
    Gottardi, E
    Alberti, D
    Pane, F
    Salvatore, F
    Saglio, G
    Baccarani, M
    [J]. BLOOD, 2004, 103 (06) : 2284 - 2290
  • [8] Differential stability of control gene and fusion gene transcripts over time may hamper accurate quantification of minimal residual disease - a study within the Europe Against Cancer Program
    van der Velden, VHJ
    Boeckx, N
    Gonzalez, M
    Malec, M
    Barbany, G
    Lion, T
    Gottardi, E
    Pallisgaard, N
    Beillard, E
    Hop, WCJ
    Hoogeveen, PG
    Gabert, J
    van Dongen, JJM
    [J]. LEUKEMIA, 2004, 18 (04) : 884 - 886
1